Skip to main content
  1. Home
  2. Emerging Tech
  3. Photography
  4. News

As Parrot's drone sales revenue loses altitude, company announces layoffs

Add as a preferred source on Google

2016 may have been the best year yet for drone sales — but the 2.5 million drones sold last year wasn’t enough to keep Parrot from announcing a cut of a third of the company’s drone division labor force. The French company announced yesterday that it would be laying off about 190 employees in the drone division after holiday sales missed their mark by about 15 percent.

The Washington Post says 2016 was a record year for drone sales, with about half, or nearly 1.2 million, of those sales coming during the holidays. But the growing market has been accompanied by falling prices and increased competition, and Parrot fell short of its goals to the tune of over $15 million in the fourth quarter.

Recommended Videos

The company’s drone division accounted for about 63 million dollars, with 11.6 million attributable to commercial drones and the remainder to consumer models.

While those numbers are only for the last quarter of the year, the company says the pattern shows that current market performance “would be insufficient to deliver profitable growth for this business over the medium and long term.”

To ensure long-term profitability, Parrot is adjusting its strategy. The company’s plan includes a reduction in the overall number of products while capitalizing on the expertise the company has developed for commercially-oriented quadcopters. About 290 staff members will be laid off out of the company’s 840 employees who are focused on drones. The company says 150 of those reductions will be from Parrot’s France-based locations with the rest being carried out in other nations.

While drones continue to soar in popularity, Parrot is likely having trouble competing with the Chinese manufacturer DJI. Since DJI owns all the factories it uses for production, as Recode points out, the company is able to sell its drones at a lower price. That edge was also what caused 3D Robotics to focus solely on drone software and stop manufacturing drones after DJI dropped its prices.

While commercial drones made up a smaller portion of Parrot’s sales in the fourth quarter, the company plans to focus on that market, where growth in applications such as aerial inspections have accelerated.

Hillary K. Grigonis
Hillary never planned on becoming a photographer—and then she was handed a camera at her first writing job and she's been…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more